All sites C00-96,D32-33,D42-43,D45-47,D76 3217 90.3 2.4 3.3 1.0 2.9
Mouth, pharynx C00-14 46 93.5 2.2 0.9 1.3 2.2
  Lip C00 6 96.7 - - 3.3 -
  Tongue C02 10 98.0 - - 2.0 -
  Mouth, other C03-06 12 93.2 - 1.7 - 5.1
  Salivary glands C07-08 8 81.6 7.9 2.6 2.6 5.3
  Pharynx C01,C09-14 11 96.4 3.6 - - -
Digestive organs C15-26 578 82.3 1.9 8.9 2.4 4.5
  Oesophagus C15 19 90.4 - 5.3 3.2 1.1
  Stomach C16 56 93.6 0.7 2.5 0.7 2.5
  Small intestine C17 10 89.6 - 6.3 2.1 2.1
  Colon C18 190 94.7 - 2.5 1.1 1.7
  Rectum, rectosigmoid C19-20 100 96.0 - 0.8 1.4 1.8
  Anus C21 4 85.0 5.0 - 10.0 -
  Liver C22 37 71.7 1.6 18.7 4.8 3.2
  Gallbladder, bile ducts C23-24 40 65.8 4.0 17.6 2.0 10.6
  Pancreas C25 109 54.7 7.4 23.9 4.2 9.8
  Other digestive organs C26 13 41.5 1.5 21.5 12.3 23.1
Respiratory organs C30-39 150 75.5 10.9 8.5 0.8 4.3
  Nose, sinuses C30-31 3 100.0 - - - -
  Larynx, epiglottis C32 3 100.0 - - - -
  Lung, trachea C33-34 141 75.7 11.5 8.1 0.7 4.0
  Mediastinum, pleura C38 2 37.5 - 62.5 - -
Bone C40-41 4 94.7 - 5.3 - -
Melanoma of the skin C43 130 99.8 - - - 0.2
Skin, non-melanoma C44 198 99.6 0.1 0.1 - 0.2
Mesothelioma C45 3 100.0 - - - -
Autonomic nervous system C47 0 100.0 - - - -
Soft tissues C48-49 20 98.0 - - - 2.0
Breast C50 1024 99.3 0.2 0.1 0.2 0.2
Female genital organs C51-58 369 95.6 1.6 0.9 0.5 1.4
  Cervix uteri C53 33 97.6 0.6 0.6 1.2 -
  Corpus uteri C54 196 99.7 - 0.1 - 0.2
  Uterus, other C55,C58 1 57.1 - 14.3 - 28.6
  Ovary C56 95 88.9 5.0 2.5 0.8 2.7
  Other female genital C51-52,C57 43 91.7 2.3 0.9 1.4 3.7
Urinary organs C64-68 141 89.1 0.8 4.2 1.3 4.5
  Kidney C64 86 86.0 - 6.0 1.4 6.5
  Bladder and urinary tract2 C65-68 55 93.8 2.2 1.4 1.1 1.4
Eye C69 3 53.8 7.7 23.1 15.4 -
Brain, central nervous system C70-72,D32-33,D42-43 114 84.5 - 8.8 1.1 5.6
Thyroid gland C73 65 96.6 3.1 - - 0.3
Other endocrine glands C74-75 3 93.8 - - - 6.3
Illdefined or unknown C76,C80 92 53.5 12.6 17.6 5.0 11.3
Lymphoid and haematopoietic tissue C81-96,D45-47,D76 276 76.4 9.7 2.0 1.6 10.3
  Hodgkin lymphoma C81 13 100.0 - - - -
  Non-Hodgkin lymphoma C82-86,C96,D76 123 99.2 - 0.2 0.2 0.5
  Malignant immunoproliferative diseases C88 3 73.3 6.7 - - 20.0
  Myeloma and other plasma cell tumors C90 37 51.9 8.1 11.9 5.4 22.7
  Leukaemia C91-95 62 61.9 22.9 0.6 2.3 12.3
  Myelodysplastic syndromes D46 14 22.5 31.0 2.8 2.8 40.8
  Myeloproliferaitive neoplasms D45,D47 23 53.4 21.6 - 1.7 23.3
Not included above
  Carcinoma in situ of the breast D05 84 100.0 - - - -
  Cervix uteri, non-invasive neoplasms 246 100.0 - - - -
  Borderline tumour of the ovary D39 35 98.8 - 0.6 - 0.6
  Basal cell carcinoma of the skin 909 100.0 - - - -
1 The following order of preference for confirmation of the diagnosis is used:
1. Histology (including autopsy, and bone marrow and blood smear examination in leukaemias)
2. Cytology
3. Surgery (including endoscopy), autopsy without histology, X-ray and some specified laboratory examinations
4. Clinical examination only
2 PUNLMP and ca in situ of the uroepithelium are included.